NGEN

NERVGEN PHARMA CORP

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

NERVGEN PHARMA CORP (NGEN) is held as common stock by 1 tracked hedge-fund manager, with a combined reported value of ~$81.9K; the largest are Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Quiet

Common-stock holders11 also report options

Congress trades0

Price$1.92vs quarter-end-6.80%

Sectors0

This quarter's moves

New1

Added0

Trimmed / sold0

Top holder

Izzy Englander

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $57.3K— of portfolio27,8002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$57.3K	27,800	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.